Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced ...
Researchers aim to develop a swallowable smart pill that temporarily operates in the gut to gently adjust nerve activity linked to stress.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results